COMMUNIQUÉS West-GlobeNewswire

INmune Bio Inc. Announces USPTO Allowance of Key Patent Covering Its DN-TNFa Platform Technology for Treating Cancer
12/09/2019
LA JOLLA, Calif., Sept. 12, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage immunology company focused on developing treatments that reprogram the patient’s innate immune system to fight [...]
ARCA Biopharma President and CEO Dr. Michael Bristow to Present at HFSA 2019 Excellence in Translational Science Symposium
12/09/2019
WESTMINSTER, Colo., Sept. 12, 2019 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for [...]
Stigma costs lives: MHCC challenges federal candidates to lead debate on mental health in 2019 election
12/09/2019
From Mental Health Commission of Canada OTTAWA, Sept. 12, 2019 (GLOBE NEWSWIRE) -- With the federal election officially underway, the Mental Health Commission of Canada (MHCC) is challenging all parties to lead a [...]
La stigmatisation coûte des vies : La CSMC lance un défi aux candidats fédéraux, celui de mener des débats sur la santé mentale dans le cadre de la campagne électorale 2019
12/09/2019
De la Commission de la santé mentale du Canada OTTAWA, 12 sept. 2019 (GLOBE NEWSWIRE) -- Avec le début officiel de campagne électorale, la Commission de la santé mentale du Canada (CSMC) lance un défi à tous les partis [...]
Blueberries Medical Announces Internationally Renowned Medical & Scientific Committee
12/09/2019
TORONTO, Sept. 12, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “ Company ” or " Blueberries "), a leading Latin American licensed producer of medicinal cannabis and [...]
Apellis Pharmaceuticals Announces Pricing of Offering of Convertible Senior Notes
12/09/2019
CRESTWOOD, Ky., and WALTHAM, Mass., Sept. 12, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals , Inc. (Nasdaq:APLS), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds [...]
Progressive Care Inc. Subsidiaries PharmCo and Family Physicians Ranked in the Top 25% in the Nation by Humana
12/09/2019
MIAMI, Sept. 12, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that its wholly owned subsidiaries PharmCo, LLC and Family [...]
Auransa Announces CEO to Participate on Executive Leadership Panel at the 6th Annual Indy Big Data Conference
12/09/2019
PALO ALTO, Calif., Sept. 12, 2019 (GLOBE NEWSWIRE) -- Auransa Inc., an artificial intelligence (AI)-driven biotechnology company developing precision medicines in areas of significant unmet medical need, today announced [...]
Koa Accel Launches as New Type of Medical Device Accelerator, Embedding Expert, Invested Teams to Drive Innovations Forward, Faster, to Reduce Investor Risk
12/09/2019
IRVINE, Calif., Sept. 12, 2019 (GLOBE NEWSWIRE) -- In a move to develop medical devices faster, at a lower cost, and with a greater likelihood of a successful exit, Koa Accel today announced its launch as a next [...]
Gritstone Oncology Announces Changes to its Board of Directors, Including the Appointment of Biotech Veteran Dr. Elaine V. Jones
12/09/2019
EMERYVILLE, Calif., Sept. 12, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer [...]
Salarius Pharmaceuticals Supports Childhood Cancer Awareness Month
12/09/2019
Salarius’ lead program, Seclidemstat, is in a Phase 1 clinical trial for Ewing sarcoma, a rare and devastating pediatric bone and soft-tissue cancer; Early cohort data expected in 2020 HOUSTON, Sept. 12, 2019 (GLOBE [...]
Immunomedics to Host Investor Event and Webcast on September 28, 2019 During ESMO Congress
12/09/2019
MORRIS PLAINS, N.J., Sept. 12, 2019 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today [...]
Alimera Announces Expansion of Agreement with Distribution Partner Horus Pharma to Include Marketing ILUVIEN® in Benelux Countries
12/09/2019
Following successful launch of ILUVIEN in France, Horus will bring the product to patients in Belgium, the Netherlands, and Luxembourg ATLANTA, Sept. 12, 2019 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“ [...]
MRI Interventions to Present at Sidoti Conference
12/09/2019
IRVINE, Calif., Sept. 12, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (NYSE American: MRIC) today announced that Chief Executive Officer Joe Burnett will present at the at the Sidoti Fall Investor Conference on [...]
AMAG Sends Letter to Shareholders
12/09/2019
Urges Shareholders Take No Action On Caligan Consent Solicitation WALTHAM, Mass., Sept. 12, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) (“AMAG” or the “Company”) today issued the following letter, [...]
CareDx launches AlloSeq® cfDNA at ESOT 2019
12/09/2019
CareDx will establish access to dd-cfDNA surveillance solutions for transplant patients worldwide BRISBANE, Calif., Sept. 12, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company [...]
Bhang Inks Deal with Cannavative Group to Manufacture and Distribute Award-Winning THC-Infused Chocolates in Nevada
12/09/2019
Bhang’s award-winning chocolates will be available in nearly 65 outlets in Nevada MIAMI, Sept. 12, 2019 (GLOBE NEWSWIRE) -- Bhang Inc. (“Bhang” or the “Company”) (CSE: BHNG) (OTCQX: BHNGF) , a global cannabis house of [...]
Ovid Therapeutics Announces First Patient Randomized in Pivotal Phase 3 NEPTUNE Trial of OV101 for the Treatment of Angelman Syndrome
12/09/2019
OV101 May Become the First Medicine for Individuals with Angelman Syndrome; Topline Results Expected in Mid-2020 NEW YORK, Sept. 12, 2019 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical [...]
BioSig Technologies Signs a New Licensing Agreement with Mayo Clinic
12/09/2019
New Agreement to Support Development of Advanced Features of PURE EP™ System Westport, CT, Sept. 12, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical technology company developing a [...]

Pages